CHAMPIONS ONCOLOGY, INC. Total Liabilities
CHAMPIONS ONCOLOGY, INC. (CSBR) had Total Liabilities of $28.83 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-09-11
- 2026-07-31: Liabilities $28.83M.
- 2026-04-30: Liabilities $22.92M.
- 2026-01-31: Liabilities $24.07M.
- 2025-10-31: Liabilities $25.93M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-07-31 | $28.83M 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $22.92M 10-Q · filed 2026-09-11 | |
| 2026-01-31 | $24.07M 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $25.93M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $27.01M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $28.57M 10-K · filed 2026-07-27 | |
| 2025-01-31 | $25.16M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $24.56M 10-Q · filed 2024-12-16 | |
| 2024-07-31 | $25.27M 10-Q · filed 2024-09-13 | |
| 2024-04-30 | $28.04M 10-K · filed 2025-07-23 | |
| 2024-01-31 | $28.84M 10-Q · filed 2024-03-15 | |
| 2023-10-31 | $28.20M 10-Q · filed 2023-12-13 | |
| 2023-07-31 | $28.00M 10-Q · filed 2023-09-13 | |
| 2023-04-30 | $29.68M 10-K · filed 2024-07-19 | |
| 2023-01-31 | $29.09M 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $27.19M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $25.41M 10-Q · filed 2022-09-12 | |
| 2022-04-30 | $26.28M 10-K · filed 2023-07-24 | |
| 2022-01-31 | $24.35M 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $21.23M 10-Q · filed 2021-12-13 | |
| 2021-07-31 | $20.57M 10-Q · filed 2021-09-13 | |
| 2021-04-30 | $20.16M 10-K · filed 2022-07-22 | |
| 2021-01-31 | $17.17M 10-K · filed 2021-07-26 | $17.39M 10-Q · filed 2021-03-15 |
| 2020-10-31 | $18.87M 10-Q · filed 2020-12-14 | |
| 2020-07-31 | $17.31M 10-Q · filed 2020-09-14 | |
| 2020-04-30 | $15.65M 10-K · filed 2021-07-26 | $15.43M 10-K · filed 2020-07-28 |
| 2020-01-31 | $11.90M 10-Q · filed 2020-03-16 | |
| 2019-10-31 | $11.83M 10-Q · filed 2019-12-16 | |
| 2019-07-31 | $11.63M 10-Q · filed 2019-09-16 | |
| 2019-04-30 | $9.03M 10-K · filed 2020-07-28 | |
| 2019-01-31 | $8.59M 10-Q · filed 2019-03-18 | |
| 2018-10-31 | $8.25M 10-Q · filed 2018-12-17 | |
| 2018-07-31 | $7.79M 10-Q · filed 2018-09-14 | |
| 2018-04-30 | $8.07M 10-K · filed 2019-07-29 | |
| 2018-01-31 | $6.62M 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $6.12M 10-Q · filed 2017-12-15 | |
| 2017-07-31 | $6.18M 10-Q · filed 2017-09-14 | |
| 2017-04-30 | $7.61M 10-K · filed 2018-07-30 | |
| 2017-01-31 | $5.51M 10-Q · filed 2017-03-17 | |
| 2016-10-31 | $4.84M 10-Q · filed 2016-12-14 | |
| 2016-07-31 | $4.67M 10-Q · filed 2016-09-14 | |
| 2016-04-30 | $5.54M 10-K · filed 2017-07-28 | |
| 2016-01-31 | $4.89M 10-Q · filed 2016-03-16 | |
| 2015-10-31 | $3.48M 10-Q · filed 2015-12-15 | |
| 2015-07-31 | $3.94M 10-Q · filed 2015-09-11 | |
| 2015-04-30 | $3.99M 10-K · filed 2016-07-29 | |
| 2015-01-31 | $6.98M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $5.17M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $5.24M 10-Q · filed 2014-09-12 | |
| 2014-04-30 | $5.67M 10-K · filed 2015-07-29 | |
| 2014-01-31 | $5.99M 10-Q · filed 2014-03-14 | |
| 2013-10-31 | $6.36M 10-Q · filed 2013-12-13 | |
| 2013-07-31 | $4.68M 10-Q · filed 2013-09-13 | |
| 2013-04-30 | $3.98M 10-K · filed 2014-07-28 | |
| 2013-01-31 | $3.68M 10-Q · filed 2013-03-13 | |
| 2012-10-31 | $3.25M 10-Q · filed 2012-12-13 | |
| 2012-07-31 | $2.82M 10-Q · filed 2012-09-12 | |
| 2012-04-30 | $4.04M 10-K · filed 2013-07-26 | |
| 2012-01-31 | $4.09M 10-Q · filed 2012-03-14 | |
| 2011-10-31 | $4.10M 10-Q · filed 2011-12-14 | |
| 2011-07-31 | $4.63M 10-Q · filed 2011-09-13 | |
| 2011-04-30 | $4.47M 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |